Your browser doesn't support javascript.
loading
[Values of Detecting the Levels of ß2-MG, TNF-α, CRP, IL-6 in the Patients with Multiple Myeloma].
Duan, Li-Juan; Li, Chao; Yang, Ru-Yu.
Afiliación
  • Duan LJ; Department of Hematology, Nanyang Central Hospital of Henan Province, Nanyang 473009, Henan Province, China.
  • Li C; Department of Hematology, Nanyang Central Hospital of Henan Province, Nanyang 473009, Henan Province, China.
  • Yang RY; Department of Hematology, Nanyang Central Hospital of Henan Province, Nanyang 473009, Henan Province, China. E-mail: 1034066216@qq.com.
Zhongguo Shi Yan Xue Ye Xue Za Zhi ; 23(5): 1362-5, 2015 Oct.
Article en Zh | MEDLINE | ID: mdl-26524038
ABSTRACT

OBJECTIVE:

To explore the values of detecting the serum levels of ß2-MG, TNF-α, CRP, IL-6 in the patients with multiple myeloma.

METHODS:

A total of 40 patents with multiple myeloma were included in the experiment group, and 40 healthy volunteers were selected as the control group. The levels of ß2-MG, TNF-α, CRP and IL-6 were detected and compared in 2 groups, the different durie-salmon (DS) stages of ß2-MG, TNF-α, CRP and IL-6 in the experiment group were analyzed.

RESULTS:

The levels of ß2-MG, CRP, IL-6 in the experiment group were higher than those in control group (P < 0.05); the level of TNF-α in the experiment group was lower than that in control group (P < 0.05); the levels of ß2-MG, CRP, IL-6 at stage I, II, III in the experiment group was higher than those in control group (P < 0.05); the level of TNF-α at stage I, II, III in the experiment group was lower than that in the control group (P < 0.05); the levels of ß2-MG, CRP, IL-6 at stage I, II, III in the experiment group displayed an increasing tendency, the levels of TNF-α at stage I, II, III in the experiment group displayed a declining trend (P < 0.05); the levels of ß2-MG, CRP, IL-6 in the experiment group after treatment for 8, 16 weeks were higher than those in control group (P < 0.05); the level of TNF-α in the experiment group after treatment for 8, 16 weeks was lower than that in control group (P < 0.05); the levels of ß2-MG, CRP and IL-6 in the experiment group after treatment for 16 weeks were lower than those for 8 weeks (P < 0.05); the levels of TNF-α in the experiment group after treatment for 16 weeks were higher than those for 8 weeks (P < 0.05). The levels of APE1 after treatment in the experiment group were lower than that before treatment.

CONCLUSION:

The serum levels of ß2-MG, TNF-α, CRP and IL-6 can be as index for diagnosis of multiple myeloma, can effectively evaluate the disease severity; their combination with APE1 expression level can evaluate the therapeutic efficacy; thus the detection of above-mentioned indexes is possessed of higher value for clinical applications.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Proteína C-Reactiva / Microglobulina beta-2 / Interleucina-6 / Factor de Necrosis Tumoral alfa / Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Observational_studies Idioma: Zh Revista: Zhongguo Shi Yan Xue Ye Xue Za Zhi Asunto de la revista: HEMATOLOGIA Año: 2015 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Proteína C-Reactiva / Microglobulina beta-2 / Interleucina-6 / Factor de Necrosis Tumoral alfa / Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Observational_studies Idioma: Zh Revista: Zhongguo Shi Yan Xue Ye Xue Za Zhi Asunto de la revista: HEMATOLOGIA Año: 2015 Tipo del documento: Article